In this article, released on 29 January on Health Europa, Nathalie Moll addresses how EFPIA intends to meet the challenge set out in the EU President's Mission letter to Stella Kyriakides, the new Health Commissioner.

"Broadly speaking, that means novel, flexible and collaborative models to solve issues of access to and shortages of medicines. It means supporting a stable, predictable regulatory environment with strong incentives to drive research into the next generation of treatments; and the adoption of a renewed industrial strategy for Europe to ensure the industry remains an innovator and world leader", declares Nathalie Moll.